386 related articles for article (PubMed ID: 23424222)
1. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
[TBL] [Abstract][Full Text] [Related]
4. [Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].
Zakliaz'minskaia EV; Shestak AG; Revishvili ASh; Pronicheva IV; Podoliak DG; Nechaenko MA; Poliakov AV; Dzemeshkevich SL
Khirurgiia (Mosk); 2013; (2):49-53. PubMed ID: 23503384
[TBL] [Abstract][Full Text] [Related]
5. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
[TBL] [Abstract][Full Text] [Related]
6. Dual phenotypic transmission in Brugada syndrome.
Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
[TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of Two Novel Mutations in
Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
9. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
[TBL] [Abstract][Full Text] [Related]
10. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
11. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
[TBL] [Abstract][Full Text] [Related]
12. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
[TBL] [Abstract][Full Text] [Related]
13. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
[TBL] [Abstract][Full Text] [Related]
15. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
Maury P; Moreau A; Hidden-Lucet F; Leenhardt A; Fressart V; Berthet M; Denjoy I; Bennamar N; Rollin A; Cardin C; Guicheney P; Chahine M
J Interv Card Electrophysiol; 2013 Aug; 37(2):131-40. PubMed ID: 23612926
[TBL] [Abstract][Full Text] [Related]
16. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
[TBL] [Abstract][Full Text] [Related]
17. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
[TBL] [Abstract][Full Text] [Related]
18. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
Barajas-Martínez H; Hu D; Antzelevitch C
Arch Cardiol Mex; 2013; 83(4):295-302. PubMed ID: 24269159
[TBL] [Abstract][Full Text] [Related]
19. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
[TBL] [Abstract][Full Text] [Related]
20. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
